Atorvastatin acts synergistically with N-acetyl cysteine to provide therapeutic advantage against Fas-activated erythrocyte apoptosis during chronic arsenic exposure in rats

Toxicology and Applied Pharmacology

Volumn 250, Issue 1, 2011, Pages 39-53

  Biswas, Debabrata ^a   Sen, Gargi ^a   Sarkar, Avik ^a   Biswas, Tuli ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

Author keywords

Apoptosis; Arsenic; Atorvastatin; Erythrocyte; Fas signaling; N acetyl cysteine

Indexed keywords

ACETYLCYSTEINE; ARSENIC; ATORVASTATIN; CASPASE 3; CHOLESTEROL; IMMUNOGLOBULIN G; PHOSPHATIDYLSERINE; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ARSENIC POISONING; ARTICLE; CELL SURFACE; CONTROLLED STUDY; DEATH; ERYTHROCYTE; ERYTHROCYTE MEMBRANE; LIFESPAN; MACROPHAGE; MALE; NONHUMAN; OPSONIZATION; PHAGOCYTOSIS; PROTEIN AGGREGATION; RAT; TREATMENT RESPONSE;

ACETYLCYSTEINE; ANIMALS; ANTICHOLESTEREMIC AGENTS; ANTIGENS, CD95; APOPTOSIS; ARSENIC; ARSENIC POISONING; CELL MEMBRANE; DRUG SYNERGISM; ENVIRONMENTAL POLLUTANTS; ERYTHROCYTES; FREE RADICAL SCAVENGERS; GLUTATHIONE; HEPTANOIC ACIDS; MALE; OXIDATIVE STRESS; PYRROLES; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

AMBYSTOMA TIGRINUM STEBBENSI VIRUS; ANIMALIA; RATTUS;

EID: 78649635023     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2010.10.002     Document Type: Article

References (65)

1. Abell L.L., Levy B.B., Brodie B.B., Kendal F.E. A simplified method for the estimation of total cholesterol in serum and demonstration of its specificity. J. Biol. Chem. 1952, 195:357-366.
2. Aguilar M.V., Martinex-Para M.C., Gonzalez M.J. Effects of arsenic (V)-chromium (III) interaction on plasma glucose and cholesterol levels in rats. Ann. Nutr. Metab. 1997, 41:189-195.
3. Allan D., Hagelberg C., Kallen K.J., Haest C.W.M. Echinocytosis and microvesiculation of human erythrocytes induced by insertion of merocyanine 540 into the outer membrane leaflet. Biochim. Biophys. Acta 1989, 986:115-122.
4. Allan D., Thomas P., Limbrick A.R. The isolation and characterization of 60nm vesicles ('nanovesicles') produced during ionophore A23187-induced budding of human erythrocytes. Biochem. J. 1980, 188:881-887.
5. Arguelles S., Machado A., Ayala A. Adduct formation of 4-hydroxynonenal and malondialdehyde with elongation factor-2 in vitro and in vivo. Free Radic. Biol. Med. 2009, 47:324-330.
6. Atkuri K.R., Mantovani J.J., Herzenberg L.A., Herzenberg L.A. N-acetylcysteine - a safe antidote for cysteine/glutathione deficiency. Curr. Opin. Pharmacol. 2007, 7:1-5.
7. Banner W., Koch M., Capin D.M., Hopf S.B., Chang S., Tong T.G. Experimental chelation therapy in chromium, lead, and boron intoxication with N-acetylcysteine and other compounds. Toxicol. Appl. Pharmacol. 1986, 83:142-147.
8. Bevers E.M., Comfurius P., Zwaal R.F. Regulatory mechanisms in maintenance and modulation of transmembrane lipid asymmetry: pathophysiological implications. Lupus 1996, 5:480-487.
9. Biswas D., Banerjee M., Sen G., Das J.K., Banerjee A., Sau T.J., Pandit S., Giri A.K., Biswas T. Mechanism of erythrocyte death in human population exposed to arsenic through drinking water. Toxicol. Appl. Pharmacol. 2008, 230:57-66.
10. Biswas D., Sen G., Biswas T. Reduced cellular redox status induces 4-hydroxynonenal-mediated caspase 3 activation leading to erythrocyte death during chronic arsenic exposure in rats. Toxicol. Appl. Pharmacol. 2010, 244:315-327.
11. Bosco E.E., Mulloy J.C., Zheng Y. Rac1 GTPase: A "Rac" of all trades. Cell. Mol. Life Sci. 2009, 66:370-374.
12. Brown D.A., London E. Structure and function of sphingolipid- and cholesterol-rich membrane rafts. J. Biol. Chem. 2000, 275:17221-17224.
13. Cahuzac N., Baum W., Kirkin V., Conchonaud F., Wawrezinieck L., Marguet D., Janssen O., Zornig M., Hueber A. Fas ligand is localized to membrane rafts, where it displays increased cell death-inducing activity. Blood 2006, 107:2384-2391.
14. Carini M., Aldini G., Facino R.M. Mass spectrometry for detection of 4-hydroxy-trans-2-nonenal (HNE) adducts with peptides and proteins. Mass Spectrom. Rev. 2004, 23:281-305.
15. Chabanel A., Flamm M., Sung K.L.P., Lee M.M., Schachter D., Chien S. Influence of cholesterol content on red cell membrane viscoelasticity and fluidity. Biophys. J. 1983, 44:171-176.
16. Charras G.T., Hu C., Coughlin M., Mitchison T.J. Reassembly of contractile actin cortex in cell blebs. J. Cell Biol. 2006, 175:477-490.
17. Chowdhury U.K., Biswas B.K., Chowdhury T.R., Samanta G., Mandal B.K., Basu G.C., Chanda C.R., Lodh D., Saha K.C., Mukherjee S.K., Roy S., Kabir S., Quamruzzaman Q., Chakraborti D. Groundwater arsenic contamination in Bangladesh and West Bengal, India. Environ. Health Perspect. 2000, 108:393-397.
18. Cibickova L., Radomir H., Stanislav M., Norbert C., Helena Z., Daniel J., Alena T., Eva B., Vladimir P. The influence of simvastatin, atorvastatin and high-cholesterol diet on acetylcholinesterase activity, amyloid beta and cholesterol synthesis in rat brain. Steroids 2009, 74:13-19.
19. Daugas E., Cande C., Kroemer G. Erythrocytes: death of a mummy. Cell Death Differ. 2001, 8:1131-1133.
20. Devaus P.F. The aminophospholipid translocase: a transmembrane lipid pump - physiological significance. News Physiol. Sci. 1990, 5:53-58.
21. Dodge J.T., Mitchell C., Hanahan D.J. The preparation and chemical characteristics of hemoglobin free ghosts of human erythrocytes. Arch. Biochem. Biophys. 1963, 100:119-130.
22. Dreosti I.E. Free radical pathology and the genome. Trace Elements, Micronutrients and Free Radicals 1991, 149-168. Humana Press, Totowa, New Jersey. I.E. Dreosti (Ed.).
23. Elahi M.M., Cagampang R., Anthony F.W., Curzen N., Ohri S.K., Hanson M.A. Statin treatment in hypercholesterolemic pregnant mice reduces cardiovascular risk factors in their offspring. Hypertension 2008, 51:939-944.
24. Flora S.J.S., Bhadauria S., Kannan G.M., Singh N. Arsenic induced oxidative stress and the role of antioxidant supplementation during chelation: a review. J. Environ. Biol. 2007, 28:333-347.
25. Folch J., Less M., Stanely G.H.S. A simple method for the isolation and purification of total lipids from animal tissue. J. Biol. Chem. 1957, 226:497-509.
26. Ghavamzadeh A., Alimoghaddam K., Ghaffari S.H., Rostami S., Jahani M., Hosseini R., Mossavi A., Baybordi E., Khodabadeh A., Iravani M., Bahar B., Mortazavi Y., Totonchi M., Aghdami N. Treatment of acute promyelocytic leukemia with arsenic trioxide without ATRA and/or chemotherapy. Ann. Oncol. 2006, 17:131-134.
27. Gratzer W.B. The red cell membrane and its cytoskeleton. Biochem. J. 1981, 198:1-8.
28. Halliwell B. Antioxidants in human health and disease. Annu. Rev. Nutr. 1996, 16:33-50.
29. Huang H., Fang L., Lu S., Chou C., Luh T., Lai M. DNA-damaging reagents induce apoptosis through reactive oxygen species-dependent Fas aggregation. Oncogene 2003, 22:8168-8177.
30. Jones P., Kafonek S., Laurora I., Hunninghake D. Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study). Am. J. Cardiol. 1998, 81:582-587.
31. Kalfa T.A., Pushkaran S., Mohandas N., Hartwig J.H., Fowler V.M., Johnson J.F., Joiner C.H., Williams D.A., Zheng Y. Rac GTPases regulate the morphology and deformability of the erythrocyte cytoskeleton. Blood 2006, 108:3637-3645.
32. Kawamura S., Miyamoto S., Brown J.H. Inititation and transduction of stretch-induced RhoA and Rac1 activation through caveolae. J. Biol. Chem. 2003, 278:31111-31117.
33. Kennedy A.D., Solga M.D., Schuman T.A., Chi A.W., Lindorer M.A., Sutherland W.M., Foley P.L., Taylor R.P. An anti-C3b(i) mAb enhances complement activation, C3b(i) deposition, and killing of CD20+ cells by rituximab. Blood 2003, 101:1071-1079.
34. Liu L., Trimarchi J.R., Navarro P., Blasco M.A., Keefe D.L. Oxidative stress contributes to arsenic-induced telomere attrition, chromosome instability, and apoptosis. J. Biol. Chem. 2003, 278:31998-32004.
35. Lopez-Revuelta A., Sanchez-Gallego J.I., Hernandez-Hernandez A., Sanchez-Yague J., Llanillo M. Increase in vulnerability to oxidative damage in cholesterolmodified erythrocytes exposed to t-BuOOH. Biochim. Biophys. Acta 2005, 1734:74-85.
36. Low P.S., Waugh S.M. The role of hemoglobin denaturation and band 3 clustering in red blood cell aging. Science 1985, 227:531-533.
37. Lowry O.M., Rosebrough I.J., Farr A.L., Randal R.J. Protein measurement with folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
38. Lu M., Wang H., Li X., Lu X., Cullen W.R., Arnold L.L., Cohen S.M., Le X.C. Evidence of hemolgobin binding to arsenic as a basis for the accumulation of arsenic in rat blood. Chem. Res. Toxicol. 2004, 17:1733-1742.
39. Lutz H.U., Bussolino F., Flepp R., Fasler S., Stammler P., Kazatchkine M.D., Arese P. Naturally occurring anti-band-3 antibodies and complement together mediate phagocytosis of oxidatively stressed human erythrocytes. Proc. Nat. Acad. Sci. U.S.A. 1987, 84:7368-7372.
40. Mandal D., Mazumder A., Das P., Kundu M., Basu J. Fas-, caspase 8-, and caspase 3-dependent signaling regulates the activity of the aminophospholipid translocase and phosphatidylserine externalization in human erythrocytes. J. Biol. Chem. 2005, 280:39460-39467.
41. McEvoy L., Williamson P., Schlegel R.A. Membrane phospholipid asymmetry as a determinant of erythrocyte recognition by macrophages. Proc. Nat. Acad. Sci. U.S.A. 1986, 83:3311-3315.
42. Miller W.H., Schipper H.M., Lee J.S., Singer J., Waxman S. Mechanism of action of arsenic trioxide. Cancer Res. 2002, 62:3893-3903.
43. Nagata S. Fas-induced apoptosis, and diseases caused by its abnormality. Genes Cells 1996, 1:873-879.
44. Ozdemirler G., Kucuk S., Orhan Y., Aykac-Toker G., Uysal M. Lipid and protein peroxidation in erythrocyte membranes of hypercholesterolemic subjects. Clin. Biochem. 2001, 34:335-339.
45. Penumathsa S.V., Thirunavukkarasu M., Koneru S., Juhasz B., Zhan L., Pant R., Menon V.P., Otani H., Maulik N. Statin and resveratrol in combination induces cardioprotection against myocardial infarction in hypercholesterolemic rat. J. Mol. Cell. Cardiol. 2007, 42:508-516.
46. Saha J.C., Dikshit A.K., Bandyopadhyay M., Saha K.C. A review of arsenic poisoning and its effects on human health. Crit. Rev. Environ. Sci. Tech. 1999, 29:281-313.
47. Scheel-Toellner D., Wang K., Singh R., Majeed S., Raza K., Curnow S.J., Salmon M., Lord J.M. The death-inducing signalling complex is recruited to lipid rafts in Fas-induced apoptosis. Biochem. Biophys. Res. Commun. 2002, 297:876-879.
48. Schick B.P., Schick P.K. Cholesterol exchange in platelets, erythrocytes and megakaryocytes. Biochim. Biophys. Acta 1985, 833:281-290.
49. Scirica B.M., Cannon C.P. Treatment of elevated cholesterol. Circulation 2005, 111:e360-e363.
50. Shinitzky M., Barenholz Y. Dynamics of the hydrocarbon layer in liposomes of lecithin and sphingomyelin containing dicetylphosphate. J. Biol. Chem. 1974, 249:2652-2657.
51. Shinitzky M., Inbar M. Microviscosity parameters and protein mobility in biological membranes. Biochim. Biophys. Acta 1976, 433:133-149.
52. Simons K., Toomre D. Lipid rafts and signal transduction. Nat. Rev. Mol. Cell Biol. 2000, 1:31-39.
53. Sutherland D.A., McCall M.S. The measurement of the survival of human erythrocytes by in vivo tagging with Cr51. Blood 1955, 10:646-649.
54. Tietze F. Enzymatic method for quantitative determination of nanogram amounts of total and oxidized glutathione. Application to mammalian blood and other tissues. Anal. Biochem. 1969, 27:502-522.
55. Turini F., Arese P., Yuan J., Low P.S. Clustering of integral membrane proteins of the human erythrocyte membrane stimulates autologous IgG binding, complement deposition, and phagocytosis. J. Biol. Chem. 1991, 266:23611-23617.
56. Tyurina Y.Y., Serinkan F.B., Tyurin V.A., Kini V., Yalowich J.C., Schroit A.J., Fadeel B., Kagan V.E. Lipid antioxidant, etoposide, inhibits phosphatidylserine externalization and macrophage clearance of apoptotic cells by preventing phosphatidylserine oxidation. J. Biol. Chem. 2004, 279:6056-6064.
57. Uyesaka N., Hasegawa S., Ishioka N., Ishioka R., Shio H., Schechter A.N. Effect of superoxide anions on red cell deformability and membrane proteins. Biorheology 1992, 29:217-229.
58. Varley H. Practical Clinical Biochemistry 1962, Williams Heineman Medical Books and Interscience Books, New York.
59. Vaya A., Martinez Triguero M., Reganon E., Vila V., Martinez Sales V., Sola E., Hernandez Mijares A., Ricart A. Erythrocyte membrane composition in patients with primary hypercholesterolemia. Clin. Hemorheol. Microcirc. 2009, 41:67-72.
60. Wagner G.M., Chiu D.T., Yee M.C., Lubin B.H. Red cell vesiculation - a common membrane physiologic event. J. Lab. Clin. Med. 1986, 108:315-324.
61. Woo S.H., Park I., Park M., An S., Lee H., Jin H., Park S., Cho H., Lee S., Gwak H., Hong Y., Hong S., Rhee C.H. Arsenic trioxide sensitizes CD95/Fas-induced apoptosis through ROS-mediated upregulation of CD95/Fas by NF-κB activation. Int. J. Cancer 2004, 112:596-606.
62. Wood B.L., Gibson D.F., Tait J.F. Increased erythrocyte phosphatidylserine exposure in sickle cell disease: flow-cytometric measurement and clinical associations. Blood 1996, 88:1873-1880.
63. Wyllie A.H. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 1980, 284:555-556.
64. Yousef M.I., El-Demerdash F.M., Radwan F.M.E. Sodium arsenite induced biochemical perturbations in rats: ameliorating effect of curcumin. Food Chem. Toxicol. 2008, 46:3506-3511.
65. Zuo L., Ushio-Fukai M., Ikeda S., Hilenski L., Patrushev N., Alexander R.W. Caveolin-1 is essential for activation of Rac1 and NAD(P)H oxidase after angiotensin II type 1 receptor stimulation in vascular smooth muscle cells: role in redox signaling and vascular hypertrophy. Arterioscler. Thromb. Vasc. Biol. 2005, 25:1824-1830.